Adenovirus/viruses A replicon chimeric vector hogcholeravaccine and application thereof
A chimeric vector, adenovirus technology, applied in applications, antiviral agents, antibody medical components, etc., can solve problems such as low cell efficiency and low expression efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0030] 1 Materials and methods
[0031] 1.1 Carriers, cells, biochemical reagents
[0032] The Alphavirus replicon DNA vaccine pSFV1CS-E2 expressing CSFV E2 protein is constructed by this laboratory (this vector is constructed by the inventor's own laboratory, and its construction method is as follows: Based on the Semliki Forest Virus (SFV) replicon, add CMV promoter, SV40 Poly(A) signal and multiple cloning sites). Adenovirus vector system including adenovirus backbone vector pAdEasy-1 and adenovirus shuttle vector pShuttle-CMV and E. coli BJ5183 competent cells were purchased from Stratagene; E. coli JM109 and DH5α competent cells were preserved by our research group. HEK293 cells (purchased from Shanghai Cell Resource Center, Chinese Academy of Sciences) were cultured with DMEM medium (Gibco BRL Company) containing 10% fetal bovine serum and appropriate amount of antibiotics. The non-restriction endonucleases BsiwI, sPeI, PmeI and PacI are all products of NEBBioLabs. Th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com